Keryx

$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
CP Wire
Akebia Therapeutics
Keryx
kidney disease
M&A
vadadustat
Flag link:
$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
Akebia Therapeutics
Keryx
kidney disease
Flag link:
$18.60 Million in Sales Expected for Keryx Biopharmaceuticals (KERX) This Quarter
$18.60 Million in Sales Expected for Keryx Biopharmaceuticals (KERX) This Quarter
Daily Political
Keryx
Flag link:
Keryx Biopharma Down 17% Despite Drug Approval
Keryx Biopharma Down 17% Despite Drug Approval
Motley Fool
Keryx
FDA
Auryxia
chronic kidney disease
dialysis
Flag link:
3 Biotech Stocks With Big News Coming
3 Biotech Stocks With Big News Coming
Motley Fool
biotech
Flexion
Zilretta
osteoarthritis of the knee
Zogenix
ZX008
Dravet syndrome
Keryx
chronic kidney disease
Auryxia
Flag link:
3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock)
3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock)
Motley Fool
Zogenix
INSYS Therapeutics
Keryx
ZX008
Syndros
Auryxia
Flag link:
Keryx rebuilds supply for kidney drug
Keryx rebuilds supply for kidney drug
BioPharma Dive
Keryx
Auryxia
Patheon
chronic kidney disease
Flag link:
Keryx says Auryxia shortage 'imminent'
Keryx says Auryxia shortage 'imminent'
BioPharma Dive
Keryx
Auryxia
drug shortages
Flag link:
Keryx Biopharmaceuticals says kidney disease drug won't be available until the fourth quarter; stock halted
Keryx Biopharmaceuticals says kidney disease drug won't be available until the fourth quarter; stock halted
Marketwatch
Keryx
kidney disease
Auryxia
Flag link:
6 Biotechs Seriously on the Move
6 Biotechs Seriously on the Move
24/7 Wall St
biotech
Eleven Biotherapeutics
Achaogen
Repros Therapeutics
OncoGenex
Cellectar
Keryx
Flag link:
​Keryx reports $4.2M in quarterly revenues, beating expectations
​Keryx reports $4.2M in quarterly revenues, beating expectations
Bizjournals.com
earnings
Keryx
Flag link:
​Boston drug company Keryx continues to shake off the haters
​Boston drug company Keryx continues to shake off the haters
Bizjournals.com
Keryx
Auryxia
Flag link:
Keryx CEO 'pleased' with drug launch as firm expands in Boston
Keryx CEO 'pleased' with drug launch as firm expands in Boston
Bizjournals.com
Keryx
Boston
drug launches
Auryxia
Flag link:
Keryx Biopharma reports 1Q loss
Keryx Biopharma reports 1Q loss
Yahoo/AP
Keryx
earnings
Flag link:
Keryx Biopharmaceuticals reports fourth-quarter loss, misses expectations
Keryx Biopharmaceuticals reports fourth-quarter loss, misses expectations
Yahoo/AP
Keryx
earnings
Flag link:
Keryx drug for dialysis patients poised to challenge Genzyme
Keryx drug for dialysis patients poised to challenge Genzyme
Bizjournals.com
Keryx
dialysis
Genzyme
Auryxia
Flag link:
Keryx Biopharma misses Street 3Q forecasts
Keryx Biopharma misses Street 3Q forecasts
Yahoo/AP
earnings
Keryx
Flag link:
Keryx Biopharmaceuticals CEO Unloads $712,000 in Stock (KERX)
Keryx Biopharmaceuticals CEO Unloads $712,000 in Stock (KERX)
Sleek Money
Keryx
Flag link:
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label
TheStreet.com
Keryx
Zerenex
Flag link:
FDA approves Keryx's kidney drug with warnings, shares fall
FDA approves Keryx's kidney drug with warnings, shares fall
Yahoo/Reuters
Keryx
ferric citrate
chronic kidney disease
Flag link:

Pages